• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Myriad touts the role of genetic testing in identifying cancer risks

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 23, 2023 at 05:42: PM
via When Myriad Genetics started to plot a campaign designed to promote its MyRisk genetic testing for hereditary cancers, the company and agency partner S50 Health conducted an in-depth survey of its target audience of women over the age of 18.

article source
 




Top Bottom
Back
Quote